ANZCHOG Advocates: Canberra visit November 2023
ANZCHOG advocates for funding and better outcomes for childhood cancer in Canberra
Partners in Paediatric Cancer Trials: The Robert Connor Dawes Foundation
We talk to RCD Foundation about their partnership with ANZCHOG
First patient enrolled in Deflexifol® At Relapse Trial (DART)
Thanks to the Kids with Cancer Foundation and The Robert Connor Dawes Foundation for supporting ANZCHOG to sponsor the Deflexifol® at Relapse Trial (DART).
Funding secured for Interfant-21 study
Thanks to support from the Australian Government and The Kids’ Cancer Project, an important trial investigating a treatment protocol for infants with leukaemia will soon be opened in Australia.
The Zero Childhood Cancer Program (ZERO)
expands to include all young Australians with cancer
The expansion of ZERO, a precision medicine program for children with cancer, was announced on February 15th at The Royal Children’s Hospital in Melbourne.
Former ANZCHOG Chair Peter Downie recognised in Australia Day honours
Associate Professor Peter Downie has been appointed Member (AM) in the General Division of the Order of Australia for significant service to paediatric oncology, to teaching, and to research.
World First: Australian child first in the world to trial new brain cancer treatment
In partnership with international clinical trials group CONNECT, co-funded by the Robert Connor Dawes Foundation and Carrie's Beanies 4 Brain Cancer Foundation
An Australian first: Newly accredited diagnostic tool to transform diagnosis of children with brain cancer
Co-funded by The Robert Connor Dawes Foundation, Carrie’s Beanies 4 Brain Cancer Foundation and the Australian Federal Government, through Cancer Australia.
Acknowledging the achievements of Audrey Evans
Members of ANZCHOG were deeply saddened to hear of the passing of Audrey Evans at the age of 97, a pioneer in paediatric oncology research and patient care.